Thursday, June 27, 2019

Glenmark Pharma gets USFDA nod for cholesterol lowering drug

Glenmark Pharma gets USFDA nod for cholesterol lowering drug The approval has been granted by the the United States Food and Drug Administration (USFDA) for for Ezetimibe and Simvastatin tablets in the strengths of 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg, the company said in a statement.

from Moneycontrol Business News https://ift.tt/2LxxzZV

No comments:

Post a Comment

Sudarshan Chemical Industries acquires Germany-based world’s second biggest pigment company Heubach Group

Sudarshan Chemical Industries announced the acquisition of Heubach Group for Rs 1,180 crore. Shares surged 20% on the news. Heubach Group is...